Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Sleep and Breathing
Published in: Sleep and Breathing 2/2012

01-06-2012 | Review

Comorbid insomnia in sleep-related breathing disorders: an under-recognized association

Authors: Suhaila E. Al-Jawder, Ahmed S. BaHammam

Published in: Sleep and Breathing | Issue 2/2012

Login to get access

Abstract

Background

In the clinical practice of sleep medicine, the coexistence of common sleep disorders is not uncommon. Patients with sleep disordered breathing (SDB) may present with insomnia, and studies have shown that SDB is common among insomnia patients. Little is known about the pathophysiological mechanisms underlying this coexistence, and limited information is available regarding the impact of each disorder on the other. It is essential to consider the effect of each disorder on the other and to understand the clinical consequences anticipated when treating each disorder in isolation. The management plan should be directed toward both disorders in a systematic and evidence-based approach. Unfortunately, a consensus standard approach for the management of comorbid insomnia and SDB is not yet available.

Methods

Therefore, we have reviewed published studies that investigated insomnia in patients with different types of SBD; obstructive sleep apnea, central sleep apnea, and hypoventilation syndromes, as well as studies that assessed SBD in patients with insomnia. In addition, we reviewed the effects of SBD treatment modalities on insomnia and the effects of insomnia treatments on SBD.
Literature
1.
Bahammam AS, Aljafen B (2007) Sleep medicine service in Saudi Arabia. A quantitative assessment. Saudi Med J 28(6):917–921PubMed
2.
Punjabi NM, Welch D, Strohl K (2000) Sleep disorders in regional sleep centers: a national cooperative study. Coleman II Study Investigators. Sleep 23(4):471–480PubMed
3.
Bonnet MH, Arand DL (2010) Hyperarousal and insomnia: state of the science. Sleep Med Rev 14(1):9–15PubMedCrossRef
4.
Riemann D, Spiegelhalder K, Feige B, Voderholzer U, Berger M, Perlis M, Nissen C (2010) The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev 14(1):19–31PubMedCrossRef
5.
American Academy of Sleep Medicine (2005) International classification of sleep disorders: diagnostic and coding manual, 2nd edn. American Academy of Sleep Medicine, Westchester
6.
Young T, Peppard P (2000) Sleep-disordered breathing and cardiovascular disease: epidemiologic evidence for a relationship. Sleep 23(Suppl 4):S122–S126PubMed
7.
Guilleminault C, Eldridge FL, Dement WC (1973) Insomnia with sleep apnea: a new syndrome. Science 181(102):856–858PubMedCrossRef
8.
Krakow B, Melendrez D, Ferreira E, Clark J, Warner TD, Sisley B, Sklar D (2001) Prevalence of insomnia symptoms in patients with sleep-disordered breathing. Chest 120(6):1923–1929PubMedCrossRef
9.
Alotair H, Bahammam A (2008) Gender differences in Saudi patients with obstructive sleep apnea. Sleep Breath 12(4):323–329PubMedCrossRef
10.
Chung KF (2005) Insomnia subtypes and their relationships to daytime sleepiness in patients with obstructive sleep apnea. Respiration 72(5):460–465PubMedCrossRef
11.
Krell SB, Kapur VK (2005) Insomnia complaints in patients evaluated for obstructive sleep apnea. Sleep Breath 9(3):104–110PubMedCrossRef
12.
Smith S, Sullivan K, Hopkins W, Douglas J (2004) Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome (OSAHS). Sleep Med 5(5):449–456PubMedCrossRef
13.
Wickwire EM, Smith MT, Birnbaum S, Collop NA (2010) Sleep maintenance insomnia complaints predict poor CPAP adherence: a clinical case series. Sleep Med 11(8):772–776PubMedCrossRef
14.
15.
Chung KF (2003) Relationships between insomnia and sleep-disordered breathing. Chest 123(1):310–311, author reply 311–313PubMedCrossRef
16.
Ambrogetti A, Olson LG, Saunders NA (1991) Differences in the symptoms of men and women with obstructive sleep apnoea. Aust N Z J Med 21(6):863–866PubMedCrossRef
17.
Pillar G, Lavie P (1998) Psychiatric symptoms in sleep apnea syndrome: effects of gender and respiratory disturbance index. Chest 114(3):697–703PubMedCrossRef
18.
Shepertycky MR, Banno K, Kryger MH (2005) Differences between men and women in the clinical presentation of patients diagnosed with obstructive sleep apnea syndrome. Sleep 28(3):309–314PubMed
19.
Gold AR, Gold MS, Harris KW, Espeleta VJ, Amin MM, Broderick JE (2008) Hypersomnolence, insomnia and the pathophysiology of upper airway resistance syndrome. Sleep Med 9(6):675–683PubMedCrossRef
20.
Lichstein KL, Riedel BW, Lester KW, Aguillard RN (1999) Occult sleep apnea in a recruited sample of older adults with insomnia. J Consult Clin Psychol 67(3):405–410PubMedCrossRef
21.
Stone JMC, Hart RP, Remsberg S, Mercer J (1994) Neuropsychological functioning in older insomniacs with or without obstructive sleep apnea. Psychol Aging 9(2):231–236PubMedCrossRef
22.
BaHammam A (2004) Polysomnographic characteristics of patients with chronic insomnia. Sleep Hypn 6(4):163–168
23.
Guilleminault C, Palombini L, Poyares D, Chowdhuri S (2002) Chronic insomnia, postmenopausal women, and sleep disordered breathing: part 1. Frequency of sleep disordered breathing in a cohort. J Psychosom Res 53(1):611–615PubMedCrossRef
24.
Krakow B, Ulibarri VA, Romero EA (2010) Patients with treatment-resistant insomnia taking nightly prescription medications for sleep: a retrospective assessment of diagnostic and treatment variables. Prim Care Companion J Clin Psychiatry 12 (4). doi:10.​4088/​PCC.​09m00873bro
25.
Krakow B, Ulibarri VA, Romero E (2010) Persistent insomnia in chronic hypnotic users presenting to a sleep medical center: a retrospective chart review of 137 consecutive patients. J Nerv Ment Dis 198(10):734–741PubMedCrossRef
26.
Umlauf MG, Chasens ER, Greevy RA, Arnold J, Burgio KL, Pillion DJ (2004) Obstructive sleep apnea, nocturia and polyuria in older adults. Sleep 27(1):139–144PubMed
27.
Leiter JC, Knuth SL, Bartlett D Jr (1985) The effect of sleep deprivation on activity of the genioglossus muscle. Am Rev Respir Dis 132(6):1242–1245PubMed
28.
Desai AVMG, Grunstein R (2003) Does sleep deprivation worsen mild obstructive sleep apnea? Sleep 26:1038–1041PubMed
29.
Series F, Roy N, Marc I (1994) Effects of sleep deprivation and sleep fragmentation on upper airway collapsibility in normal subjects. Am J Respir Crit Care Med 150(2):481–485PubMed
30.
Bonnet MH, Arand DL (1995) 24-Hour metabolic rate in insomniacs and matched normal sleepers. Sleep 18(7):581–588PubMed
31.
Stepanski E, Zorick F, Roehrs T, Young D, Roth T (1988) Daytime alertness in patients with chronic insomnia compared with asymptomatic control subjects. Sleep 11(1):54–60PubMed
32.
Guilleminault CEF, Phillips JR, Dement WC (1976) Two occult causes of insomnia and their therapeutic problems. Arch Gen Psychiatry 33(10):1241–1245PubMedCrossRef
33.
Javaheri S (2006) Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol 106(1):21–28PubMedCrossRef
34.
Oldenburg OLB, Faber L, Teschler H, Horstkotte D, Topfer V (2007) Sleep-disorder breathing in patients with symptomatic heart failure. A contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 9:251–257PubMedCrossRef
35.
Brostrom A, Stromberg A, Dahlstrom U, Fridlund B (2004) Sleep difficulties, daytime sleepiness, and health-related quality of life in patients with chronic heart failure. J Cardiovasc Nurs 19(4):234–242PubMed
36.
Labanowski M, Schmidt-Nowara W, Guilleminault C (1996) Sleep and neuromuscular disease: frequency of sleep-disordered breathing in a neuromuscular disease clinic population. Neurology 47(5):1173–1180PubMed
37.
Bourke SC, Gibson GJ (2002) Sleep and breathing in neuromuscular disease. Eur Respir J 19(6):1194–1201PubMedCrossRef
38.
Klink MQS (1987) Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airways diseases. Chest 91(4):540–546PubMedCrossRef
39.
Cormick W, Olson LG, Hensley MJ, Saunders NA (1986) Nocturnal hypoxaemia and quality of sleep in patients with chronic obstructive lung disease. Thorax 41(11):846–854PubMedCrossRef
40.
van Manen JG, Bindels PJ, IJzermans CJ, van der Zee JS, Bottema BJ, Schade E (2001) Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol 54(3):287–293PubMedCrossRef
41.
Phillips BA, Cooper KR, Burke TV (1987) The effect of sleep loss on breathing in chronic obstructive pulmonary disease. Chest 91(1):29–32PubMedCrossRef
42.
Bellia VCF, Scichilone N, Incalzi RA, Spatafora M, Vergani C, Rengo F (2003) Sleep disorders in the elderly with and without chronic airflow obstruction: the SARA study. Sleep 26(3):318–323PubMed
43.
Kales A, Kales JD (1983) Sleep laboratory studies of hypnotic drugs: efficacy and withdrawal effects. J Clin Psychopharmacol 3(2):140–150PubMedCrossRef
44.
Leiter JCKS, Krol RC, Bartlett D Jr (1985) The effect of diazepam on genioglossus muscle activity in normal human subjects. Am Rev Respir Dis 132(2):216–219PubMed
45.
Maillard D, Thiercelin JF, Fuseau E, Rosenzweig P, Attali P (1992) Effects of zolpidem versus diazepam and placebo on breathing control parameters in healthy human subjects. Int J Clin Pharmacol Res 12(1):27–35PubMed
46.
Hedemark LL, Kronenberg RS (1983) Flurazepam attenuates the arousal response to CO2 during sleep in normal subjects. Am Rev Respir Dis 128(6):980–983PubMed
47.
Berry RB, McCasland CR, Light RW (1992) The effect of triazolam on the arousal response to airway occlusion during sleep in normal subjects. Am Rev Respir Dis 146(5 Pt 1):1256–1260PubMed
48.
Bezel R, Russi E, Kronauer H, Mothersill I (1987) Life-threatening apnea after midazolam administration in a patient with obstructive sleep apnea syndrome. Schweiz Med Wochenschr 117(15):579–583PubMed
49.
Dolly FR, Block AJ (1982) Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects. Am J Med 73(2):239–243PubMedCrossRef
50.
Hoijer UHJ, Ejnell H et al (1994) Nitrazepam in patients with sleep apnoea: a double-blind placebo-controlled study. Eur Respir J 7:2011–2015PubMed
51.
Camacho ME, Morin CM (1995) The effect of temazepam on respiration in elderly insomniacs with mild sleep apnea. Sleep 18(8):644–645PubMed
52.
Nickol AHLJ, Richards P, Seal P, Harris GA, Cleland J, Dubowitz G, Collier DJ, Milledge J, Stradling JR, Morrell MJ (2006) Temazepam at high altitude reduces periodic breathing without impairing next-day performance: a randomized cross-over double-blind study. J Sleep Res 15(4):445–454PubMedCrossRef
53.
Guilleminault C, Crowe C, Quera-Salva MA, Miles L, Partinen M (1988) Periodic leg movement, sleep fragmentation and central sleep apnoea in two cases: reduction with clonazepam. Eur Respir J 1(8):762–765PubMed
54.
Block AJ, Dolly FR, Slayton PC (1984) Does flurazepam ingestion affect breathing and oxygenation during sleep in patients with chronic obstructive lung disease? Am Rev Respir Dis 129(2):230–233PubMed
55.
Cummiskey J, Guilleminault C, Del Rio G, Silvestri R (1983) The effects of flurazepam on sleep studies in patients with chronic obstructive pulmonary disease. Chest 84(2):143–147PubMedCrossRef
56.
Murciano D, Armengaud MH, Cramer PH, Neveux E, L'Heritier C, Pariente R, Aubier M (1993) Acute effects of zolpidem, triazolam and flunitrazepam on arterial blood gases and control of breathing in severe COPD. Eur Respir J 6(5):625–629PubMed
57.
Sanger DJ (2004) The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents. CNS Drugs 18(Suppl 1):9–15, discussion 41, 43–15PubMedCrossRef
58.
Rosenberg R, Roach JM, Scharf M, Amato DA (2007) A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome. Sleep Med 8(5):464–470PubMedCrossRef
59.
Lettieri CJ, Quast TN, Eliasson AH, Andrada T (2008) Eszopiclone improves overnight polysomnography and continuous positive airway pressure titration: a prospective, randomized, placebo-controlled trial. Sleep 31(9):1310–1316PubMed
60.
Collen J, Lettieri C, Kelly W, Roop S (2009) Clinical and polysomnographic predictors of short-term continuous positive airway pressure compliance. Chest 135(3):704–709PubMedCrossRef
61.
Lettieri CJEA, Andrada T, Khramtsov A, Kristo DA (2005) Does zolpidem enhance the yield of polysomnography? J Clin Sleep Med 1(2):129–131PubMed
62.
Berry RB, Patel PB (2006) Effect of zolpidem on the efficacy of continuous positive airway pressure as treatment for obstructive sleep apnea. Sleep 29(8):1052–1056PubMed
63.
Beaumont M, Batejat D, Coste O, Van Beers P, Colas A, Clere JM, Pierard C (2004) Effects of zolpidem and zaleplon on sleep, respiratory patterns and performance at a simulated altitude of 4,000 m. Neuropsychobiology 49(3):154–162PubMedCrossRef
64.
Beaumont M, Batejat D, Pierard C, Van Beers P, Philippe M, Leger D, Savourey G, Jouanin JC (2007) Zaleplon and zolpidem objectively alleviate sleep disturbances in mountaineers at a 3,613 meter altitude. Sleep 30(11):1527–1533PubMed
65.
Quadri S, Drake C, Hudgel DW (2009) Improvement of idiopathic central sleep apnea with zolpidem. J Clin Sleep Med 5(2):122–129PubMed
66.
Girault C, Muir JF, Mihaltan F, Borderies P, De La Giclais B, Verdure A, Samson-Dollfus D (1996) Effects of repeated administration of zolpidem on sleep, diurnal and nocturnal respiratory function, vigilance, and physical performance in patients with COPD. Chest 110(5):1203–1211PubMedCrossRef
67.
Steens RD, Pouliot Z, Millar TW, Kryger MH, George CF (1993) Effects of zolpidem and triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease. Sleep 16(4):318–326PubMed
68.
Bayliss DA, Viana F, Talley EM, Berger AJ (1997) Neuromodulation of hypoglossal motoneurons: cellular and developmental mechanisms. Respir Physiol 110(2–3):139–150PubMedCrossRef
69.
Veasey SC, Panckeri KA, Hoffman EA, Pack AI, Hendricks JC (1996) The effects of serotonin antagonists in an animal model of sleep-disordered breathing. Am J Respir Crit Care Med 153(2):776–786PubMed
70.
Veasey SC, Fenik P, Panckeri K, Pack AI, Hendricks JC (1999) The effects of trazodone with l-tryptophan on sleep-disordered breathing in the English bulldog. Am J Respir Crit Care Med 160(5 Pt 1):1659–1667PubMed
71.
Heinzer RC, White DP, Jordan AS, Lo YL, Dover L, Stevenson K, Malhotra A (2008) Trazodone increases arousal threshold in obstructive sleep apnoea. Eur Respir J 31(6):1308–1312PubMedCrossRef
72.
Carley DW, Olopade C, Ruigt GS, Radulovacki M (2007) Efficacy of mirtazapine in obstructive sleep apnea syndrome. Sleep 30(1):35–41PubMed
73.
Castillo JL, Menendez P, Segovia L, Guilleminault C (2004) Effectiveness of mirtazapine in the treatment of sleep apnea/hypopnea syndrome (SAHS). Sleep Med 5(5):507–508PubMedCrossRef
74.
Marshall NS, Yee BJ, Desai AV, Buchanan PR, Wong KK, Crompton R, Melehan KL, Zack N, Rao SG, Gendreau RM, Kranzler J, Grunstein RR (2008) Two randomized placebo-controlled trials to evaluate the efficacy and tolerability of mirtazapine for the treatment of obstructive sleep apnea. Sleep 31(6):824–831PubMed
75.
Erman M, Seiden D, Zammit G, Sainati S, Zhang J (2006) An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia. Sleep Med 7(1):17–24PubMedCrossRef
76.
Zammit G, Erman M, Wang-Weigand S, Sainati S, Zhang J, Roth T (2007) Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia. J Clin Sleep Med 3(5):495–504PubMed
77.
Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P (2006) Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia. Sleep Med 7(4):312–318PubMedCrossRef
78.
Kryger M, Wang-Weigand S, Roth T (2007) Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea. Sleep Breath 11(3):159–164PubMedCrossRef
79.
Kryger MW-WS, Zhang J, Roth T (2008) Effect of ramelteon, a selective MT(1)/MT (2)-receptor agonist, on respiration during sleep in mild to moderate COPD. Sleep Breath 12(3):243–250PubMedCrossRef
80.
Kryger M, Roth T, Wang-Weigand S, Zhang J (2009) The effects of ramelteon on respiration during sleep in subjects with moderate to severe chronic obstructive pulmonary disease. Sleep Breath 13(1):79–84PubMedCrossRef
81.
Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M (2008) Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 4(5):487–504PubMed
82.
Spielman AJ, Saskin P, Thorpy MJ (1987) Treatment of chronic insomnia by restriction of time in bed. Sleep 10(1):45–56PubMed
83.
Morin CM, Azrin NH (1987) Stimulus control and imagery training in treating sleep-maintenance insomnia. J Consult Clin Psychol 55(2):260–262PubMedCrossRef
84.
Means MK, Lichstein KL, Epperson MT, Johnson CT (2000) Relaxation therapy for insomnia: nighttime and day time effects. Behav Res Ther 38(7):665–678PubMedCrossRef
85.
Harvey AG, Sharpley AL, Ree MJ, Stinson K, Clark DM (2007) An open trial of cognitive therapy for chronic insomnia. Behav Res Ther 45(10):2491–2501PubMedCrossRef
86.
NIH State-of-the-Science Conference Statement on manifestations and management of chronic insomnia in adults (2005) NIH Consens State Sci Statements 22(2):1–30
87.
Morgenthaler T, Kramer M, Alessi C, Friedman L, Boehlecke B, Brown T, Coleman J, Kapur V, Lee-Chiong T, Owens J, Pancer J, Swick T (2006) Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American Academy of Sleep Medicine report. Sleep 29(11):1415–1419PubMed
88.
Krakow B, Melendrez D, Lee SA, Warner TD, Clark JO, Sklar D (2004) Refractory insomnia and sleep-disordered breathing: a pilot study. Sleep Breath 8(1):15–29PubMedCrossRef
89.
Guilleminault C, Davis K, Huynh NT (2008) Prospective randomized study of patients with insomnia and mild sleep disordered breathing. Sleep 31(11):1527–1533PubMed
90.
Giles TL, Lasserson TJ, Smith BH, White J, Wright J, Cates CJ (2006) Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 3:CD001106PubMed
91.
Wright J, White J (2000) Continuous positive airways pressure for obstructive sleep apnoea. Cochrane Database Syst Rev (2):CD001106.
92.
White J, Cates C, Wright J (2002) Continuous positive airways pressure for obstructive sleep apnoea. Cochrane Database Syst Rev (2):CD001106.
93.
Marin J, Carrizo S, Vincente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea–hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046–1053PubMed
94.
Richard W, Venker J, den Herder C, Kox D, van den Berg B, Laman M, van Tinteren H, de Vries N (2007) Acceptance and long-term compliance of nCPAP in obstructive sleep apnea. Eur Arch Otorhinolaryngol 264(9):1081–1086PubMedCrossRef
95.
McArdle NDG, Heidarnejad H, Engleman HM, Mackay TW, Douglas NJ (1999) Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 159:1108–1114PubMed
96.
Krieger J (1992) Long-term compliance with nasal continuous positive airway pressure (CPAP) in obstructive sleep apnea patients and nonapneic snorers. Sleep 15(6 Suppl):S42–S46PubMed
97.
Lettieri CJ, Shah AA, Holley AB, Kelly WF, Chang AS, Roop SA (2009) Effects of a short course of eszopiclone on continuous positive airway pressure adherence: a randomized trial. Ann Intern Med 151(10):696–702PubMed
98.
Budhiraja RPS, Drake CL, Roth T, Sharief I, Budhiraja P, Saunders V, Hudgel DW (2007) Early CPAP use identifies subsequent adherence to CPAP therapy. Sleep 30(3):320–324PubMed
99.
Chasens ER, Pack AI, Maislin G, Dinges DF, Weaver TE (2005) Claustrophobia and adherence to CPAP treatment. West J Nurs Res 27(3):307–321PubMedCrossRef
100.
Nguyên XLCJ, Rakotonanahary D, Fleury B (2010) Insomnia symptoms and CPAP compliance in OSAS patients: a descriptive study using data mining methods. Sleep Med 11(8):777–784PubMedCrossRef
101.
Smith I, Nadig V, Lasserson TJ (2009) Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines for adults with obstructive sleep apnoea. Cochrane Database Syst Rev (2):CD007736.
102.
Haynes PL (2005) The role of behavioral sleep medicine in the assessment and treatment of sleep disordered breathing. Clin Psychol Rev 25(5):673–705PubMedCrossRef
103.
Krakow B, Ulibarri V, Melendrez D, Kikta S, Togami L, Haynes P (2008) A daytime, abbreviated cardio-respiratory sleep study (CPT 95807–52) to acclimate insomnia patients with sleep disordered breathing to positive airway pressure (PAP-NAP). J Clin Sleep Med 4(3):212–222PubMed
104.
AlDabal L, BaHammam AS (2010) Cheyne-Stokes respiration in patients with heart failure. Lung 188(1):5–14PubMedCrossRef
105.
Pinto AC, Evangelista T, Carvalho M, Alves MA, Sales Luis ML (1995) Respiratory assistance with a non-invasive ventilator (Bipap) in MND/ALS patients: survival rates in a controlled trial. J Neurol Sci 129(Suppl):19–26PubMedCrossRef
106.
Kleopa KA, Sherman M, Neal B, Romano GJ, Heiman-Patterson T (1999) Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci 164(1):82–88PubMedCrossRef
107.
Lyall RA, Donaldson N, Fleming T, Wood C, Newsom-Davis I, Polkey MI, Leigh PN, Moxham J (2001) A prospective study of quality of life in ALS patients treated with noninvasive ventilation. Neurology 57(1):153–156PubMed
108.
Barbe F, Quera-Salva MA, de Lattre J, Gajdos P, Agusti AG (1996) Long-term effects of nasal intermittent positive-pressure ventilation on pulmonary function and sleep architecture in patients with neuromuscular diseases. Chest 110(5):1179–1183PubMedCrossRef
109.
Piper AJ, Wang D, Yee BJ, Barnes DJ, Grunstein RR (2008) Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation. Thorax 63(5):395–401PubMedCrossRef
110.
Martin RJ, Bartelson BL, Smith P, Hudgel DW, Lewis D, Pohl G, Koker P, Souhrada JF (1999) Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD. Chest 115(5):1338–1345PubMedCrossRef
111.
Krakow B, Melendrez D, Pedersen B, Johnston L, Hollifield M, Germain A, Koss M, Warner TD, Schrader R (2001) Complex insomnia: insomnia and sleep-disordered breathing in a consecutive series of crime victims with nightmares and PTSD. Biol Psychiatry 49(11):948–953PubMedCrossRef
112.
Gooneratne NS, Gehrman PR, Nkwuo JE, Bellamy SL, Schutte-Rodin S, Dinges DF, Pack AI (2006) Consequences of comorbid insomnia symptoms and sleep-related breathing disorder in elderly subjects. Arch Intern Med 166(16):1732–1738PubMedCrossRef
Metadata
Title
Comorbid insomnia in sleep-related breathing disorders: an under-recognized association
Authors
Suhaila E. Al-Jawder
Ahmed S. BaHammam
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Sleep and Breathing / Issue 2/2012
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-011-0513-1

Other articles of this Issue 2/2012

Sleep and Breathing 2/2012 Go to the issue

Original Article

Is obstructive sleep apnea syndrome a risk factor for auditory pathway?

Original Article

Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome in nonobese adults

Case Report

Free-running (non-entrained to 24-h period) circadian sleep disorder in a patient with obstructive sleep apnea, delayed sleep phase tendency, and lack of social interaction

Book Review

N. Foldray-Schaefer, J. Krishna, K. Budur (eds): a case a week: sleep disorders from the Cleveland clinic

Original Article

Association between osteoporosis and sleep duration in healthy middle-aged and elderly adults: a large-scale, cross-sectional study in Japan

Editorial (invited)

Cerebral response to obstructive apnea: the times they are a-changin'
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits